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Objective.Todeterminewhetherthereisanassociationbetween smokingandthelocationofacutemyocardialinfarctions.Methods.
UsingacohortfromourhospitalandpublishedcohortsfromIreland, Uruguay, andIsrael,wecalculated odds ofhavinganinferior
wall as opposed to an anterior wall acute myocardialinfarction amongsmokers and nonsmokers.Results.I no u rc o h o r t ,t h e r ew a s
a higher proportion of smokers than nonsmokers in patients with inferior acute myocardial infarctions than in patients with
anterior infarctions. This diﬀerence was also present in each of the other cohorts. Odds ratios for an inferior versus an anterior
acute myocardialinfarctionamongsmokersranged from 1.15to 2.00 (medianodds ratio,1.32).Whenthe cohorts were combined
(n = 3,160), the pooled odds ratio for an inferior as opposed to an anterior acute myocardial infarction among smokers was
1.38 (95% conﬁdence interval, 1.20 to 1.58) (P<. 002). Conclusions. Cigarette smoking increases the risk of inferior wall acute
myocardial infarction more than the risk of anterior wall infarction. Smoking thus appears to adversely aﬀe c tt h er i g h tc o r o n a r y
arterial circulation to a greater extent than the left coronary arterial circulation by a mechanism not yet understood.
1.Introduction
Cigarette smoking is a major, independent risk factor for
coronary heart disease (CHD) and acute myocardial infarc-
tion (AMI) [1, 2]. The mechanism for the adverse eﬀect of
cigarettesmokingonthecoronaryarterialcirculationiscom-
plex and multifactorial.
Smoking increases both heart rate and blood pressure
(and therefore the rate-pressure product), thereby augment-
ing myocardial oxygen demand. Simultaneously, smoking
reduces the dimension of the coronary arteries and coro-
nary blood ﬂow [3]. Whether smoking-induced coronary
vasoconstriction and reduced coronary blood ﬂow aﬀect the
right and left coronary arterial systems equally and whether
smoking constricts normal and diseased arteries to a similar
degree is uncertain.
Inferior wall AMI is usually a consequence of disease in
the right coronary arterial system, whereas anterior wall
AMI is usually a consequence of disease in the left coronary
arterial system. The purpose of the present study was to
examine whether smoking inﬂuences the location of AMI
(inferior wall versus anterior wall). To accomplish this pur-
pose,weexaminedarecentcohortofpatientswithAMIfrom
our own institution, all of whom had undergone coronary
angiography at the time of their AMI [4]. We also examined
data from published cohorts from Ireland, Uruguay, and
Israel [5–8].We employedidenticalmethodologiestoextract
datafromthesereportsandtocalculatetheoddsofhavingan
inferior as opposed to an anterior AMI among smokers and
nonsmokers.
2.Methods
Details of our cohort of AMI patients have been described
elsewhere [4]. Most of the patients (174, or 98%) had
presented with inferior or anterior wall STEMI (98%); the
other 4 (2%) had presented with AMI associated with left
bundle branch block.Every patient in this cohort underwent
coronary angiography, almost always emergently, and the
infarct-related culprit artery was identiﬁed (Table 1). As
anticipated, the right coronary artery was the culprit in over2 ISRN Cardiology
Table 1: Dallas AMI cohort [4]: culprit artery in relation to the
location of the AMI.
Inferior AMI
(n = 107)
Anterior AMI
(n = 71)
RCA 88 (82.2%)∗ 0
LCX 13 (12.1%) 2 (2.8%)
LAD 4 (3.7%) 69 (97.1%)†
LCX/LAD 1 (0.9%) 0
Ramus branch 1 (0.9%) 0
AMI: acute myocardialinfarction; LAD: leftanteriordescendingartery or its
branches; LCX: left circumﬂex artery or its branches; RCA: right coronary
artery or its branches.
∗a single anomalous RCA supplied the entire left ventricle in one inferior
AMI patient.
†Distal left main/LAD lesion was the culprit artery in one patient, LAD/
ramus in another.
80% of the patients with inferior AMI, while the left anterior
descending artery was the culprit in over 95% of the patients
with anterior AMI.
We also searched the print and online literature for other
AMI cohorts that, like ours, were classiﬁed as inferior or
anterior AMI patients and also as smokers or nonsmokers.
Four additional cohorts, listed in Table 2, fulﬁlled these cri-
teria [5–8].
We uniformly extracted data from the text or tables of
each report. We expressed data as percentages of smokers in
theinferior andtheanterior AMIgroups.Foreachstudy,and
for the pooled cohorts, we calculated the odds ratio (and its
95% conﬁdence interval) of having an inferior AMI relative
to an anterior AMI among smokers. We also calculated the
z-ratio and the corresponding P value using pooled data.
3.Results
As shown in Table 3, the prevalence of smoking diﬀered con-
siderably among the ﬁve cohorts analyzed. The prevalence of
smoking ranged from 41.9% to 84.7% among patients with
inferior AMI and from 36.4% to 74.4% among patients with
anterior AMI. In each of the cohorts examined, however,
smokers were overrepresented in the inferior AMI groups
compared to the anterior AMI groups.
Odds ratios for an inferior relative to anterior AMI
among smokers in the ﬁve cohorts ranged from 1.15 to 2.00
(median, 1.32). The pooled odds ratio for the combined
cohorts was 1.38 (95% conﬁdence interval, 1.20–1.58). This
diﬀerence was statistically signiﬁcant (z-ratio, 4.491; 2P<
.002). The pooled data reﬂected an 8% higher incidence
of smoking in inferior versus anterior AMI patients (95%
conﬁdence interval for the diﬀerence, 4.5–11.4%).
4.Discussion
The purpose of our study was to accept or reject the null
hypothesis that smoking would be equally associated with
inferior and anterior wall AMI locations. In each of the
cohorts that we analyzed, spanning three decades, there were
higher percentages of smokers among patients with inferior
than anterior AMI. Conversely, nonsmokers were overrep-
resented among patients with anterior AMI. Similar trends
have been observed in clinical trials involving AMI patients
[9–11]. The consistent diﬀerence in smoking prevalence by
infarct location is intriguing and supports a hypothesis that
smoking may adversely aﬀect the right coronary arterial
circulation to a greater extent than the left circulation.
However, the mechanism(s) responsible for this apparent
selective eﬀect of smoking in CHD remains speculative.
Cigarette smoking increases the risk for AMI by multiple
and complex mechanisms. Withr e s p e c tt oa t h e r o g e n e -
sis, smoking raises serum LDL-cholesterol and triglyceride
concentrations and lowers serum HDL-cholesterol levels.
Moreover, cigarette smoke promotes free radical damage to
LDL, leading to accumulation of oxidized LDL-cholesterol
within thearterial wall. Smokingappearsto contributetothe
vascular inﬂammation characteristic of atherosclerosis, as
reﬂected by higher serum C-reactive protein levels in smok-
e r st h a ni nn o n s m o k e r s[ 1]. Whether these atherogenic
p r o c e s s e sa r em o r ep r o m i n e n ti nt h er i g h tt h a ni nt h e
left coronary arterial circulation is uncertain. Some of the
adverse eﬀects of smoking on atherogenesis may not be
rapidly reversible following smoking cessation, as progres-
sion of atherosclerosis appears to occur at similar rates in
current and former smokers [12].
Smoking, mainly through its nicotine content, activates
the sympathetic nervous system (SNS), increasing both
heart rate and systolic blood pressure. This increase in
the rate-pressure product results in increased myocardial
oxygen demands. Increased SNS activity due to nicotine
exposure also leads to coronary arterial vasoconstriction [3],
decreasing myocardial blood ﬂow at a time when oxygen
demand is increasing. In addition to increasing myocardial
oxygen demand and reducing coronary blood ﬂow, cigarette
smoking increases carboxyhemoglobin levels in the blood,
with the potential to further reduce myocardial oxygen
delivery from oxyhemoglobin. Whether coronary arterial
vasoconstriction induced by cigarette smoking is more
pronounced in the right than the left coronary circulation
is unknown. Nasal cocaine administration leads to similar
degrees of vasoconstriction in the left and right coronary
arterial systems [13]. Unfortunately, a similar comparison
has not been performed before and after cigarette smoking.
Smoking also impairs endothelial function, impairing
releaseoftissueplasminogenactivator(tPA)andprostacyclin
(PGI2), for example, which could result in local hyper-
coagulability. Cigarette smoking may further contribute to
hypercoagulability by increasing tissue factor, factor VII,
ﬁbrinogen, and hemoglobin levels. Smoking also enhances
platelet activity and interactions between platelets and the
endothelial lining of blood vessels. Whether any of these
adverse endothelial and/or prothrombotic eﬀects would
occur to a greater extent in the right than the left coronary
arterial system is a matter of speculation. Smoking also
reduces endothelial release of nitric oxide (NO), which leads
to reduced coronary ﬂow reserve.
In summary, we found that cigarette smoking is asso-
ciated more strongly with inferior than anterior AMI.
This ﬁnding suggests that the adverse eﬀects of tobacco onISRN Cardiology 3
Table 2: Deﬁnitions of smokers and nonsmokers used in the AMI cohorts.
Reference Country AMI patients Deﬁnition of smokers Deﬁnition of nonsmokers
[4] USA 178 Current and former smokers Lifelong nonsmokers
[5] Ireland 697 Current and former smokers Lifelong nonsmokers
[6] Uruguay 788 Current and former smokers Lifelong nonsmokers
[7] Israel 637 Current smokers and recent quitters∗ Lifelong nonsmokersand former smokers†
[8] Israel 666 Not stated Not stated
∗Patients who had quit smoking less than 1 month prior to their AMI.
†Patients who had quit smoking more than 1 month prior to their AMI.
Table 3:Smokers(%) amonginferiorand anterior AMI patients in
the ﬁve cohorts.
Reference Inferior AMI
(%)
Anterior AMI
(%) Odds ratio (95% CI)
[4] 67.3 50.7 2.00 (1.08–3.70)
[5] 84.7 74.4 1.90 (1.30–2.78)
[6] 43.2 36.5 1.32 (1.03–1.73)
[7] 41.9 36.4 1.26 (0.92–1.74)
[8] 47.5 44.1 1.15 (0.85–1.57)
Pooled 54.85 46.86 1.38 (1.20–1.58)
AMI: acute myocardial infarction; CI: conﬁdence interval.
coronary atherogenesis and/or endothelial dysfunction may
be more pronounced in the right than the left coronary
arterial circulation. Despite the statistically signiﬁcant asso-
ciation with smoking and the location of an AMI, the
diﬀerence in smoking prevalence was modest (8%; 95%
CI, 4.5–11.4%). Furthermore, there was still nearly a 50%
prevalence of smoking among pooled patients with anterior
AMI, which tend to be larger, and more lethal, than inferior
AMI. This latter observation emphasizes the importance of
smoking in the pathogenesis of both inferior and anterior
AMI and the critical role of smoking avoidance and smoking
cessation in primary and secondary prevention of AMI
[14]. Since passive smoking exposure increases the risk of
CHD and AMI in nonsmokers, smoking cessation can also
substantially reduce the risk of AMI in nonsmokers [14].
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